Goodrich J M, Williams E S, Buskirk S W
Department of Zoology and Physiology University of Wyoming, Laramie 82071.
J Wildl Dis. 1994 Oct;30(4):492-6. doi: 10.7589/0090-3558-30.4.492.
We vaccinated six captive badgers housed with five controls, and monitored blood antibody titers and white cell counts of both groups for 63 days postvaccination between 29 August and 3 December 1992. Five vaccinated badgers responded with antibody titers ranging from 1:64 to 1:1024 by 63 days postvaccination, whereas the sixth badger did not respond. Treatment badgers also had significant (P < 0.05) decreases in lymphocytes on days 16, 29, and 63. No badgers developed clinical signs of distemper. Control badgers did not produce antibodies against CD virus; thus, the vaccine virus probably was not transmitted between treatment and control animals. The vaccine appears safe for use in healthy badgers, but additional safety and efficacy study is needed.
我们给6只圈养獾接种了疫苗,同时设置了5只作为对照,在1992年8月29日至12月3日期间,对接种疫苗后的两组獾的血液抗体滴度和白细胞计数进行了63天的监测。到接种疫苗后63天时,5只接种疫苗的獾产生了抗体滴度,范围从1:64到1:1024,而第6只獾没有产生反应。在第16天、29天和63天时,接种疫苗的獾的淋巴细胞数量也出现了显著(P < 0.05)下降。没有獾出现犬瘟热的临床症状。对照獾没有产生针对CD病毒的抗体;因此,疫苗病毒可能没有在接种疫苗的动物和对照动物之间传播。该疫苗似乎可安全用于健康的獾,但还需要进行更多的安全性和有效性研究。